Weight-Loss Injections Spark Muscle Loss Crisis, Study Reveals Rapid Aging of Bodily Functions by 10 Years

(New York, 17th, Comprehensive Foreign Report) GLP-1 agonist drugs for weight loss, such as 'skinny shots,' have taken the world by storm. However, research shows that while these drugs reduce fat, they may also cause rapid muscle mass loss, akin to aging the body's functions by 10 years, leading to side effects like weakness and decreased metabolism, sparking academic concern over a 'frailty crisis.' The Wall Street Journal reports that GLP-1 drugs, initially used for chronic conditions like obesity and type 2 diabetes, are increasingly being marketed as a 'lifestyle solution.' In the United States, these drugs have helped many people lose weight, leading to a decline in obesity rates, a significant reduction in food consumption, and retailers reporting lower sales of plus-size clothing, improving the health and quality of life for millions. However, for the 13 million Americans using these drugs, some are losing muscle along with fat. This unexpected side effect is not immediately apparent and has not yet been widely discussed. An analysis published by the American Diabetes Association shows that these drugs can cause a rapid and significant loss of muscle mass, up to 10%, which is equivalent to aging the body's functions by more than a decade. Doctors and researchers note that while muscle loss is similar to that from dieting, a substantial loss in a short period can lead to weakness, instability, and poor coordination. Another concern is that muscle loss can lower a patient's metabolic rate, leading to weight regain. Daniel Green, the lead researcher from the University of Western Australia who participated in the analysis, said, 'We are treating obesity by promoting frailty.' Many users feel good when they initially lose fat but soon start to feel weak and lethargic. Green's research shows that regular weight training can effectively slow the rate of muscle loss. He believes, 'The drug packaging should include a note: 'Must be used in conjunction with weight training.' Rayna Kingston, a 30-year-old woman from Denver, said she felt extremely tired the day after her injection, able to do little more than basic chores. She switched her injection day to Sunday because Monday was her least busy day. She was so weak after the injection that her partner had to bring meals to her in bed. She stopped exercising for this reason and said her doctor never gave her guidance on strength training or maintaining muscle mass. 'I had to rely on Reddit to understand what was happening to my body,' she said, and stopped the medication after less than two months. Pharmaceutical companies state that weight-loss drugs should only be taken under a doctor's recommendation and in conjunction with a long-term plan including diet and exercise. An Eli Lilly spokesperson stated that FDA guidelines clearly indicate that 'physical activity should be increased' when using these drugs. Both Eli Lilly and Novo Nordisk said that clinical trials show users do lose some muscle mass, but far less than fat. Eli Lilly further noted that users lose three times as much weight in fat as they do in muscle. Experts say that for people over 50, those with osteoporosis, or mobility issues, losing muscle at this rate is dangerous and can increase the risk of injury. A recent study published in the British Medical Journal (BMJ) showed that people using GLP-1 drugs regained weight four times faster than those who lost weight through lifestyle changes, and what they regained was almost all fat. Researchers state there is currently little guidance or research on how to discontinue the drugs. Women may be more susceptible to the side effects of these drugs, which also include nausea, diarrhea, migraines, and, more rarely, pancreatitis. Scientists are calling for more clinical trials to clarify the full impact of these weight-loss drugs on muscle loss across different populations.